Antonio Oliver

Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC

Gabriel Cabot, Sebastian Bruchmann, Xavier Mulet et al. · Antimicrobial Agents and Chemotherapy · 2014 · 242 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

Gabriel Cabot, Alain A. Ocampo-Sosa, M.Á. Domínguez et al. · Antimicrobial Agents and Chemotherapy · 2012 · 222 citations · Full text

Life Sciences, Genetics, Microbiology +17

Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates

Gabriel Cabot, Laura Zamorano, Bartolomé Moyá et al. · Antimicrobial Agents and Chemotherapy · 2016 · 209 citations · Full text

Life Sciences, Evolutionary Biology, Microbiology +17

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

Pablo A. Fraile-Ribot, Gabriel Cabot, Xavier Mulet et al. · Journal of Antimicrobial Chemotherapy · 2017 · 203 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Stepwise Upregulation of the<i>Pseudomonas aeruginosa</i>Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues

Carlos Juan, Bartolomé Moyá, José Luis Pérez et al. · Antimicrobial Agents and Chemotherapy · 2006 · 165 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17